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Background: Medicinal plants have been used traditionally in Golestan province (north of Iran), against Mycobacterium tuberculosis or the clinical signs of tuberculosis (TB).
Objectives: This study aimed to define the inhibitory effects of ethanolic extracts of six of these medicinal plants against Mycobacterium 
tuberculosis.
Materials and Methods: Peganum harmala (seed extract), Punica granatum (peel extract), Digitalis sp. (leaf extract), fruit extract of Citrus 
lemon, Rosa canina and Berberis vulgaris were extracted in ethanol and their activity against M. tuberculosis isolates were determined by the agar diffusion method. The zone of inhibition (at 200 to 1.6 mg/mL) was measured and the results were compared with isoniazid and rifampin as standard positive controls. Also the concentration of vitamin C of each the extracts was evaluated.
Results: The ethanolic extract of Peganum harmala seed and Punica granatum peel exhibited potential activity against all M. tuberculosis isolates with mean inhibitory zone of 18.7 and 18.8 mm, at 200 mg/mL concentration. The mean inhibitory zone around isoniazid and rifampinwere 19.2 and 18.8 mm. Ethanolic extract of Citrus lemon showed moderate inhibitory activity only against sensitive (non MDR; non multi drug resistant) strains of M. tuberculosis, and Digitalis sp. showed inhibitory effects on five isolates. Ascorbic acid content was 43.3 mg/dL in Punica granatum and Digitalis sp. and only 9.1 mg/dL in ethanolic extract of Peganum harmala.
Conclusions: The highest content of vitamin C was observed in the extract of Punica granatum, which was observed to be highly active against Mycobacterium tuberculosis, while the P. harmala must have contained other phytochemical constituents that contributed to the anti-tuberculosis effects of this plant. Our findings showed that ethanolic extracts of P. granatum and P. harmala had anti-TB effects comparable to isoniazid and rifampin and can be good candidates for novel and safe natural products against tuberculosis.
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1. BackgroundTuberculosis (TB) is one of the major fatal infectious diseases in the world (1). It has infected one-third of the world’s population and is responsible for approximately 2 million deaths each year, mostly in developing coun-tries (2). In 2010, approximately 8.8 million new cases of active TB was reported and 1.1 million people died from the disease, most of which happened in develop-ing countries (3). Tuberculosis typically affects the lungs and spreads from an infected person to a susceptible person (4). This infection requires a long duration of therapy, which is six months for first-line drugs, includ-ing isoniazid, rifampin, ethambutol and pyrazinamide (5). In certain situations (for example, bacterial drug resistance and intolerance), second-line drugs are used, mostly based on high-risk medications, such as fluoro-quinolones, capreomycin, ethionamide and cycloserine, that are usually less effective and more toxic with side ef-
fects for the patient (6). The improper use of these drugs results in increasing prevalence of multi-drug resistant (MDR) and extensively drug resistant (XDR) strains of M. 
tuberculosis that are resistantto both first and second-line drugs (7). Therefore there is an urgent need to search for complementary medicines or new alternatives of antibi-otics, especially from natural sources, which work more effectively with fewer side effects (8, 9). Medicinal plants have been used for this purpose in many countries to pre-vent and treat infectious diseases (10). Antioxidants such as vitamin C, tocopherols, carotenoids, polyphones and flavonoids may be responsible for the antibacterial activ-ity of medicinal plants. Many studies have found an as-sociation between anti-tuberculosis activity of medicinal plant extracts and their vitamin C content, which can be an importantfinding (11). Tuberculosis has been a threat-ening disease in Iran from the distant past. According to 
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the world health organization, the estimated incidence rate of TB in the Islamic Republic of Iran was 21 cases per 100000 people in 2011. The Golestan province, located in the south-east of the Caspian sea has the highest in-cidence of TB in Iran (12).This province due to its diverse climatic and heterogeneous ecological condition is able to grow many plants, especially medicinal plants, and the search for finding medicinal plants that inhibit the growth of Mycobacterium tuberculosis is of great impor-tance in this region.
2. ObjectivesThe present study aimed to investigate the anti-M. tu-
berculosis activity of six medicinal plants in the region against Mycobacterium tuberculosis for the management of the tuberculosis disease.
3. Materials and Methods
3.1. Preparation of Plant SamplesSix medicinal plants were selected for the present study. The selected plants namely Citrus lemon (Rutaceae), 
Peganum harmala (zigophyllaceae), Punica granatum (Ly-thraceae), Rosa canina (Rosaceae), Berberis vulgaris (Ber-beridaceae), Digitalis sp. (Scrophulariaceae) had shown anti-mycobacterial activity against non-pathogenic my-cobacteria in a previous study (13). The selected plants were collected from ranges as high as 650-2250 m and from three regions Ziaret, Deraznoo and Charbagh, lo-cated south ofGolestan province from July to September 2012. Table 1 presents the scientific name, local names and their uses in traditional medicine.The method of Alade and Irobi (14) was used for the extraction of plant extracts with minor modifications. Briefly the plants were air-dried in the dark at room tem-perature and then ground into fine powder using an electric blender. Plant hydro-alcoholic extracts were pre-pared by the maceration method; 30 g of each dried pow-der was soaked in 100 mL of 70% ethanol for 72 hours. A sterile glass rod was used for stirring each mixture every 24 hours. The plant extracts were filtered twice through Whatman filter paper no. 1 (Whatman, UK). The obtained 
filtrates were evaporated using a rotary evaporator. The final products were sticky-brown substances and stored in a laboratory refrigerator prior to the test. The concen-trated extract was freshly dissolved in dimethyl sulfoxide (DMSO) before use.
3.2. Preparation of InoculumsIn the present study a total of seven isolates of Myco-
bacterium tuberculosis were used; six clinical isolates were identified by conventional methods including two MDR and four sensitive isolates to rifampin and isonia-zid, which were isolated from sputum of tuberculosis patients in Gorgan. Also a drug-susceptible strain of M. 
tuberculosis (H37Rv), which was sensitive to rifampin and isoniazid, was kindly provided by Dr. Hashemi (Ahvaz University of Medical Sciences, Ahvaz, Iran). The bacterial cultures, which were used to prepare the standard inocu-lums, were maintained on Lowenstein-Jensen medium (Merck). A suspension of each bacterium was prepared in normal saline containing 0.05% Tween-80 and adjusted approximately to McFarland 0.5 standard (15).
3.3. Anti M. tuberculosis ActivityAntibacterial activity was determined by the disk diffu-sion method (16, 17). One hundred microliters of myco-bacterial suspension was spread onto the surface of Low-enstein Jenson media, using a sterile glass spreader. The extracts were dissolved in 2% DMSO (Sigma) to obtain a concentration of 200 mg/mL and further diluted to their final concentrations. The final concentration of DMSO in all assays was 2% or less, which is nontoxic for mycobacte-ria (18). Sterile paper disks (6 mm diameter) were loaded 
with 40 μL of extract (varying concentrations: 200, 100, 50, 25, 12.5, 6.25, 3.12 and 1.6 mg/mL) and then left to dry. The impregnated-disks were then placed on the surface of plates on which the microorganisms were cultured. Rifampin (MAST) and Isoniazid (SIGMA-ALDRICH) was used as the positive control and disks treated with 2% DMSO were used as the negative control. The culture plates were sealed in plastic bags and incubated at 37°C for three weeks, after which culture-growth was clearly visible on the agar. The clear zone visible all around the 
Table 1. Ethnobotanical Information of Selected Medicinal Plants
Plants Local Name Family Part(s) Used Preparation Used Therapeutic Use
Citrus lemon Limoo Rutaceae fruit pulp decoction, powder, fresh juice cold, fever, flu, bronchitis
Peganum 
harmala
Esphand zygophyllaceae seed soaked eaten respiratory and nervous system diseases, cough, stomachache
Punica 
granatium
Anar Punicaceae peel cooked raw antibiotic, urinary tract infections, anti-inflammation, cold, flu
Rosa canina Nastaran Rosaceae fruit decoction preventive for flu
Berberis 
vulgaris
Zereshk Berberidaceae fruit decoction dysentery, sedative, malaria, anti-inflammatory
Digitalis sp. Angoshtane Scrophulariaceae Leaf fresh water of Leaf, liquid extract anti-inflammatory, anti-oxidant, antipyretic, antirheumatic, stimulatory forthe immune system
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impregnated-disk was indicative of the inhibitory effects. The diameter of the zone of inhibition around each of the disks was measured and recorded. Each experiment was performed in triplicates.
3.4. Measurement of Vitamin CThe concentration of vitamin C in each extractwas mea-sured using the colorimetric method (19). In short, 0.2 g 
of vitamin C powder as the standard and 500 μL of the stock solutions of each plant extract were mixed with metaphosphoric acid 6g/dL and centrifuged at 3000 rpm for 10 minutes. Next, 1.2 mL of the supernatant from each of the tubes were combined with a mixture containing copper sulphate 0.6%, thiourea5% and diphenyl hydra-zine 2%. After three hours of incubationin a water bath at 37°C, 2 mL of sulphuric acid 12 M was added to each tube. The content of vitamin C in each sample was measured by reading the absorbance in a spectrophotometer at OD of 520 nm. This experiment was carried out in duplicates.
4. Results
4.1. Anti M. tuberculosis ActivityAmongst the hydro-alcoholic extracts of the six selected medicinal plants, fruit extracts of Berberis vulgaris and 
Rosa canina showed no inhibitory activity against Myco-
bacterium tuberculosis. Extract of Punica granatum even at concentration of 25 mg/mL could prevent the growth of all M. tuberculosis isolates while the extract of Peganum 
harmalahad this property ata concentration of 50 mg/mL (Table 2). Ethanolic extract of Citrus lemon could prevent the growth of non-MDR Mycobacterium tuberculosis iso-lates while theethanolic extract of Digitalis sp. showed a mild anti-M. tuberculosis activity at concentrations of 200 and 100 mg/mL. Isoniazid and rifampin showed inhibi-tory effects only against non-MDR M. tuberculosis isolates. The zone of growth inhibition and the number of isolates which showed inhibitory effects were decreased with decreasing concentrations of ethanolic extracts, so that 
Citrus lemon extract at concentration of 200 and 25 mg/mL inhibited the growth of four and one M. tuberculosis isolates, respectively. Although, ethanolic extract of Digi-
talis sp. at a concentration of 200 mg/mL could inhibit the growth of five M. tuberculosis isolates, none of isolates were inhibited at a concentration of 50 mg/mL (Table 2).Anti-TB activity was shown by extracts of Punica gra-
natum and Peganum harmala on sensitive and resistant strains of Mycobacterium tuberculosis. The maximum zone of inhibition against an MDR strain was observed with extract of Punica granatum (19.5 ± 3.5 mm) and against a non-MDR strain by extract of Peganum harmala (19 ± 2.6 mm) as compared with the standard rifampin (19.5 ± 2.4 mm) and isoniazid (19.5 ± 2.1 mm).
Table 2. Anti-Tuberculosis Activity of Selected Medicinal Plants Against Multi-Drug Resistant and Non-Multi-Drug Resistant M. tubercu-
losis a
Concentrations, mg/mL H37RV MDR1 MDR2 Non MDR1 Non MDR2 Non MDR3 Non MDR4 Mean
MDR Non MDR
Citrus lemon200 10 R R 20 20 R 10 R 12.50 ± 9.6100 R R R 15 15 R R R 7.50 ± 8.750 R R R 8 10 R R R 4.50 ± 5.325 R R R R 8 R R R 2.00 ± 4.0
Peganumharmala200 18 20 17 18 22 20 16 18.50 ± 2.1 19.00 ± 2.6100 15 16 15 15 15 15 12 15.50 ± 1 14.25 ± 1.550 8 12 10 14 12 12 10 11.00 ± 1.4 12.00 ± 1.625 R 10 8 12 8 10 9 9.00 ± 1.4 9.75 ± 1.7
Punicagaranatium200 20 22 17 18 15 18 20 19.50 ± 3.5 17.75 ± 2.1100 17 18 13 15 13 15 16 15.50 ± 3.5 14.75 ± 1.350 15 15 10 13 10 14 13 12.50 ± 3.5 12.50 ± 1.725 13 10 8 10 8 10 8 9.00 ± 1.4 9.00 ± 1.2
Digitalis Sp.200 R R 12 12 12 12 14 6.00 ± 6 12.50 ± 1100 R R R 10 10 10 10 R 1050 R R R R R R R R R25 R R R R R R R R R
Isoniazid, μg/mL2 18 R R 17 22 20 19 R 19.50 ± 2.1
Rifampin, μg/mL5 16 R R 18 23 19 18 R 19.50 ± 2.4a Abbreviations: MDR, multiple-drug resistant; Non MDR, non-multiple-drug resistant.
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Table 3. Level of Vitamin C of Selected Medicinal Plants
Name of the Plant OD Concentration(mg/dL)
Punica granatum 0.300 43.3
Digitalis sp. 0.300 43.3
Berberis vulgaris 0.285 41.1
Rosa canina 0.145 20.9
Citrus lemon 0.078 11.3
Peganum harmala 0.063 9.1
4.2. Measurement of Vitamin C LevelThe level of vitamin C in ethanolic extracts of the select-ed plants are presented in Table 3. Extract of Punica grana-
tum and Digitalis sp. with vitamin C amount 43.3 mg/dL showed the maximum level of vitamin C.
5. DiscussionIn the present study, selection of medicinal plants was based on a previous study, conducted by Ghaemi et al. (13). The plants were used for the treatment of tuberculo-sis, chronic respiratory diseases or symptoms of diseases, by local healers in this area. Ghaemi et al. reported that among the 52 herbal plants examined, only six extracts had good anti-mycobacterial activity against two non-pathogenic strains of M. bovis BCG and M. smegmatis (13). Therefore, the present study aimed to evaluate the inhibi-tory effects of these six medicinal plants on the growth of 
Mycobacterium tuberculosis, as the most important patho-genic mycobacteria. Among these plants only the etha-nolic extracts of Peganum harmala and Punica granatum showed potential inhibitory effects against M. tuberculo-
sis. Similarly, Gautam et al. (20) found anti-mycobacterial activity by ethanolic extracts of P. harmala and P. grana-
tum. Also Ghaemi et al. showed that ethanolic extracts of 
P. granatum have greater effects on M. bovis compared to 
M. smegmatis. Pomegranate is an edible fruit, which na-tively grows in Iran and many studies have been done on its biological properties that confirm the therapeutic properties of this plant. Pomegranate has a wide range of bioactive compounds such as: alkaloids, ellagic acid, Punicalagin, ellagitannins, anthocyanin, flavonoids and tannins. Due to presence of these compounds it has vari-ous pharmacological activities such as, antioxidant, anti-microbial and anti-virus (21) and has been used to treat respiratory diseases (22). In addition to its antibacterial activities against Escherichia coli (23) and Staphylococcus 
aureus (24), we found that the peel extracts of pomegran-ate have a great potential to be used as anti-TB agents. The ethanolic extract of Peganum harmala followed by the extract of Punica granatum showed strong anti-TB ac-tivity against M. tuberculosis. In two studies, conducted by Gautam et al. and Ghaemi et al. it was demonstrated that theethanolic extract of this plant was active against 
M. smegmatis (13, 20) and M. bovis (13). Peganum harmala is known as “Espand’’ in Iran (25) and has been used tradi-tionally in Turkey, Iran and China to treat coughs, rheu-
matism, high blood pressure, diabetes and asthma (26). The seed and root extracts of P. harmala have broad anti-bacterial activity against gram-positive and negative-bac-teria (25). The most pharmacological active compounds of P. harmala are alkaloids (27). Ghaemi et al. reported that ethanolic extracts of Citrus lemon have strong inhibi-tory activity against M. smegmatis but limited inhibitory activity on M. bovis. In another study,Kirbaslar et al.(28) showed that Citrus lemon peel oil was active against M. 
phlei and M. smegmatis,as indicated by the disk diffusion assay with an inhibitory zone equal to 13 mm. Saeed et al. (29) reported that Citrus lemon juice had antibacterial ac-tivity against a range of gram-positive and negative bac-teria. Citrus lemon has been used traditionally as an anti-inflammatory, antiseptic, expectorant and relaxingagent (13). In the present study we found that this extract has moderate activity against M. tuberculosis. Thus, high con-centrations of this extract may be effective in controlling the growth of M. tuberculosis. It is interesting to note that the extract of Citrus lemon only showed inhibitory activity against isoniazid and rifampin-sensitive isolates. Citrus 
lemon is a native plant of India that belongs to the Ruta-ceae family and is widely cultivated in Iran including the Golestan province, located north of Iran. Anti-bacterial, anti-fungal, anti-viral, anti-cancer and anti-diabetic activ-ity of this plant is due to the presence of flavonoids and alkaloids in its crude extracts (30). Similar to the results obtained by Ghaemi et al. (13), in this study, we found weak activity for ethanolic extracts of Digitalis sp. against 
M. tuberculosis, therefore in vitro anti-tuberculosis activ-ity of this plant is not remarkable. This plant may be effec-tive in other ways, such as boosting the immune system to inhibit the growth of TB in the body. Recently, poten-tial activity of vitamin C has been shown to be part of the dramatic killing of sensitive and resistant strains of My-
cobacterium tuberculosis in vitro (11). Narwadiya et al. (31) supports the fact that as the concentration of vitamin C increases in plant extracts there is evidence of decrease in the number of tubercle bacilli; a claim that is some what confirmed by our result. Our findings demonstrat-ed that Punica granatum (peel) has a high concentration of vitamin C and showed maximum activity against M. 
tuberculosis, yet Digitalis sp. (leaf) although it has a high concentration of vitamin C, it did not show anti-tubercu-losis activity. On the other hand, Peganum harmala (seed) had the minimum concentration of Vitamin C among all examined plants of this study, yet it showed potential ac-tivity against the tubercle bacilli. Therefore, vitamin C by itself is not sufficient for the inhibitory effect of extracts of medicinal plants against M. tuberculosis. The reason behind these observations needs further investigations. The peel of ethanolic extracts of Punica granatum and the seed extracts of Peganum harmala exhibited significant inhibitory activity in vitro. According to our findings, we can conclude that the high concentration of vitamin C in the P. granatum extract can justify its anti-tuberculosis effect. On the other hand, P. harmala extract does not 
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contain enough vitamin C, thus it may contain other phytochemical constituents that contribute to the anti–tuberculosis effects in this plant. These medicinal plants as promising candidates and may be used as novel natu-ral products without any side effects for new anti-TB drug discovery. The application of these two extracts either in cell culture or animal models is recommend, to evaluate their growth inhibitory effects on M. tuberculosis.
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